According to CASI Pharmaceuticals's latest financial reports the company's current earnings are A$22.05 Million. In 2023 the company made an earning of -A$42.31 Million, an increase over its 2022 earnings that were of -A$60.04 Million. The earnings displayed on this page is the company's Pretax Income.